| __timestamp | ImmunityBio, Inc. | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 641000 | 580415000 |
| Thursday, January 1, 2015 | 236000 | 1032336000 |
| Friday, January 1, 2016 | 44000 | 1702177000 |
| Sunday, January 1, 2017 | 45000 | 2488652000 |
| Monday, January 1, 2018 | 47000 | 3047597000 |
| Tuesday, January 1, 2019 | 2202000 | 4162821000 |
| Wednesday, January 1, 2020 | 605000 | 6205683000 |
| Friday, January 1, 2021 | 934000 | 7574400000 |
| Saturday, January 1, 2022 | 240000 | 8930700000 |
| Sunday, January 1, 2023 | 622000 | 9869200000 |
| Monday, January 1, 2024 | 11020100000 |
In pursuit of knowledge
In the competitive world of biotechnology, revenue growth is a key indicator of success. Over the past decade, Vertex Pharmaceuticals Incorporated has demonstrated a remarkable upward trajectory, with its revenue increasing by over 1,600% from 2014 to 2023. In contrast, ImmunityBio, Inc. has experienced a more volatile journey, with its revenue peaking in 2019 before stabilizing at lower levels.
Vertex's revenue growth is a testament to its strategic focus on innovative treatments, particularly in the realm of cystic fibrosis. By 2023, Vertex's revenue reached nearly $10 billion, showcasing its dominance in the biotech sector.
ImmunityBio's revenue, while significantly lower, highlights the challenges faced by emerging biotech firms. Despite a peak in 2019, its revenue has fluctuated, reflecting the uncertainties in drug development and market acceptance.
Johnson & Johnson vs Vertex Pharmaceuticals Incorporated: Annual Revenue Growth Compared
Vertex Pharmaceuticals Incorporated and argenx SE: A Comprehensive Revenue Analysis
Vertex Pharmaceuticals Incorporated or Jazz Pharmaceuticals plc: Who Leads in Yearly Revenue?
Who Generates More Revenue? Vertex Pharmaceuticals Incorporated or Corcept Therapeutics Incorporated
Revenue Insights: Vertex Pharmaceuticals Incorporated and ACADIA Pharmaceuticals Inc. Performance Compared
Revenue Insights: Vertex Pharmaceuticals Incorporated and Evotec SE Performance Compared
Revenue Insights: Vertex Pharmaceuticals Incorporated and Xencor, Inc. Performance Compared
United Therapeutics Corporation and ImmunityBio, Inc.: A Comprehensive Revenue Analysis
Incyte Corporation and ImmunityBio, Inc.: A Comprehensive Revenue Analysis
Annual Revenue Comparison: Catalent, Inc. vs ImmunityBio, Inc.
Revenue Insights: ImmunityBio, Inc. and Amphastar Pharmaceuticals, Inc. Performance Compared
Comparing Revenue Performance: ImmunityBio, Inc. or Novavax, Inc.?